Core Scientific, Inc. (NASDAQ:CORZ) Director Jarrod M. Patten Buys 2,240 Shares

Core Scientific, Inc. (NASDAQ:CORZGet Free Report) Director Jarrod M. Patten acquired 2,240 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were purchased at an average cost of $11.05 per share, for a total transaction of $24,752.00. Following the acquisition, the director now owns 300,000 shares in the company, valued at $3,315,000. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Core Scientific Price Performance

NASDAQ:CORZ opened at $11.18 on Tuesday. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $12.25. The firm’s fifty day moving average is $10.03 and its 200-day moving average is $6.84.

Core Scientific (NASDAQ:CORZGet Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported ($4.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($4.47). The business had revenue of $141.10 million for the quarter, compared to analyst estimates of $128.58 million. The company’s revenue was up 11.2% on a year-over-year basis. On average, research analysts forecast that Core Scientific, Inc. will post 0.01 earnings per share for the current year.

Institutional Trading of Core Scientific

Several large investors have recently modified their holdings of the stock. Banque Cantonale Vaudoise acquired a new position in shares of Core Scientific during the second quarter valued at about $28,000. Sunbelt Securities Inc. acquired a new position in Core Scientific during the 2nd quarter worth approximately $33,000. Rise Advisors LLC bought a new position in Core Scientific in the second quarter worth approximately $65,000. Aspect Partners LLC acquired a new stake in Core Scientific in the first quarter valued at approximately $29,000. Finally, Hexagon Capital Partners LLC bought a new stake in shares of Core Scientific during the first quarter valued at approximately $34,000.

Analysts Set New Price Targets

CORZ has been the topic of a number of recent research reports. Sanford C. Bernstein reissued an “outperform” rating and set a $17.00 price target on shares of Core Scientific in a research note on Tuesday, September 10th. BTIG Research boosted their target price on shares of Core Scientific from $10.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, June 26th. HC Wainwright raised their price target on shares of Core Scientific from $11.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. B. Riley raised shares of Core Scientific from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $0.50 to $13.00 in a research note on Wednesday, July 17th. Finally, Needham & Company LLC initiated coverage on Core Scientific in a research report on Wednesday, September 4th. They set a “buy” rating and a $16.00 target price for the company. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat, Core Scientific currently has an average rating of “Buy” and a consensus price target of $14.88.

View Our Latest Stock Report on CORZ

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Recommended Stories

Insider Buying and Selling by Quarter for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.